Abstract Background Bladder cancer (BLCA) is a malignant tumor with a dismay outcome. Increasing evidence has confirmed that chromatin regulators (CRs) are involved in cancer progression. Therefore. we aimed to explore the function and prognostic value of CRs in BLCA patients. https://www.jmannino.com/